首页> 美国卫生研究院文献>other >Sequential affinity purification of peroxidase tagged bispecific anti-SARS-CoV antibodies on phenylboronic acid agarose
【2h】

Sequential affinity purification of peroxidase tagged bispecific anti-SARS-CoV antibodies on phenylboronic acid agarose

机译:在苯硼酸琼脂糖上过氧化物酶标记的双特异性抗SARS-CoV抗体的顺序亲和纯化

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hybrid hybridomas (quadromas) are derived by fusing at least two hybridomas, each producing a different antibody of predefined specificity. The resulting cell secretes not only the immunoglobulins of both parents but also hybrid molecules manifesting the binding characteristics of the individual fusion partners. Purification of the desired bispecific immunoprobe with high specific activity from a mixture of bispecific and monospecific monoclonal antibodies requires special strategies. Using a dual, sequential affinity chromatography (Protein-G chromatography followed by m-aminophenyleboronic acid agarose column), we have purified bispecific monoclonal antibodies (BsMAb) as a preformed HRPO (Horseradish Peroxidase) complex (BsMAb–HRPO). The quadroma culture supernatant was initially processed on a Protein-G column to isolate all the species of immunoglobulins. This pre-enriched fraction was subsequently passed through the aminophenyleboronic acid column super saturated with HRPO. The column matrix has the ability to bind to proteins such as HRPO with vicinal diols. The enzyme loaded column captures the desired bispecific anti-SARS-CoV × anti-HRPO species with the elimination of the monospecific anti-SARS-CoV MAb to result in a high specific activity diagnostic probe. The presence of anti-HRPO MAb is an acceptable impurity as it will not bind to the target SARS-CoV NP antigen and will get washed out during the ELISA procedure.
机译:杂交杂交瘤(四倍瘤)是通过融合至少两个杂交瘤而产生的,每个杂交瘤产生具有预定特异性的不同抗体。所得的细胞不仅分泌两个亲本的免疫球蛋白,而且分泌表现出单个融合伴侣结合特性的杂合分子。从双特异性和单特异性单克隆抗体的混合物中纯化具有高特异性活性的所需双特异性免疫探针需要特殊的策略。使用双重顺序亲和色谱法(Protein-G色谱,然后用间氨基苯硼酸琼脂糖柱),我们纯化了双特异性单克隆抗体(BsMAb),作为预制的HRPO(辣根过氧化物酶)复合物(BsMAb–HRPO)。最初在蛋白质G柱上处理过正交培养物上清液,以分离所有种类的免疫球蛋白。随后使该预富集的级分通过被HRPO超饱和的氨基苯基硼酸柱。柱基质具有与邻位二醇结合蛋白质(如HRPO)的能力。装有酶的色谱柱捕获了所需的双特异性抗SARS-CoV×抗HRPO,消除了单特异性抗SARS-CoV MAb,从而获得了高比活诊断探针。抗HRPO MAb的存在是可以接受的杂质,因为它不会与目标SARS-CoV NP抗原结合,并且会在ELISA程序中被洗去。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号